Pattern of Respiratory Deterioration in Sporadic Amyotrophic Lateral Sclerosis According to Onset Lesion by Using Respiratory Function Tests

被引:4
作者
Kim, Dong-Gun [1 ]
Hong, Yoon-Ho [2 ]
Shin, Je-Young [3 ]
Lee, Kwang-Woo [3 ]
Park, Kyung Seok [1 ]
Seong, Seung-Yong [4 ]
Sung, Jung-Joon [3 ]
机构
[1] Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Neurol, Seoul 03080, South Korea
[2] Seoul Natl Univ, Coll Med, Seoul Metropolitan Govt Boramae Med Ctr, Dept Neurol, Seoul 03080, South Korea
[3] Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Dept Neurol, Seoul 03080, South Korea
[4] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Wide River Inst Immunol,Dept Microbiol & Immunol, Seoul 03080, South Korea
关键词
Amyotrophic lateral sclerosis; Respiratory function test; Maximal inspiratory pressure; Maximal expiratory pressure; Progression;
D O I
10.5607/en.2015.24.4.351
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Most amyotrophic lateral sclerosis (ALS) patients show focal onset of upper and lower motor neuron signs and spread of symptoms to other regions or the other side clinically. Progression patterns of sporadic ALS are unclear. The aim of this study was to evaluate the pattern of respiratory deterioration in sporadic ALS according to the onset site by using respiratory function tests. Study participants included 63 (42 cervical-onset [C-ALS] and 21 lumbosacral-onset [L-ALS]) ALS patients and 31 healthy controls. We compared respiratory function test parameters among the 3 groups. Age was 57.4 +/- 9.6 (mean +/- SD), 60.8 +/- 9, and 60.5 +/- 7 years, and there were 28, 15, and 20 male participants, in the C-ALS, L-ALS, and control groups, respectively. Disease duration did not differ between C-ALS and L-ALS patients. Sniff nasal inspiratory pressure (SNIP) was significantly low in C-ALS patients compared with controls. Maximal expiratory pressure (MEP) and forced vital capacity percent predicted (FVC% predicted) were significantly low in C-ALS and L-ALS patients compared with controls. Maximal inspiratory pressure to maximal expiratory pressure (MIP: MEP) ratio did not differ among the 3 groups. Eighteen C-ALS and 5 L-ALS patients were followed up..MIP,.MEP,.SNIP,.PEF, and.FVC% predicted were higher in C-ALS than L-ALS patients without statistical significance. Fourteen C-ALS (77.8%) and 3 L-ALS (60%) patients showed a constant MIP: MEP ratio above or below 1 from the first to the last evaluation. Our results suggest that vulnerability of motor neurons in sporadic ALS might follow a topographic gradient.
引用
收藏
页码:351 / 357
页数:7
相关论文
共 25 条
  • [21] A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD
    Renton, Alan E.
    Majounie, Elisa
    Waite, Adrian
    Simon-Sanchez, Javier
    Rollinson, Sara
    Gibbs, J. Raphael
    Schymick, Jennifer C.
    Laaksovirta, Hannu
    van Swieten, John C.
    Myllykangas, Liisa
    Kalimo, Hannu
    Paetau, Anders
    Abramzon, Yevgeniya
    Remes, Anne M.
    Kaganovich, Alice
    Scholz, Sonja W.
    Duckworth, Jamie
    Ding, Jinhui
    Harmer, Daniel W.
    Hernandez, Dena G.
    Johnson, Janel O.
    Mok, Kin
    Ryten, Mina
    Trabzuni, Danyah
    Guerreiro, Rita J.
    Orrell, Richard W.
    Neal, James
    Murray, Alex
    Pearson, Justin
    Jansen, Iris E.
    Sondervan, David
    Seelaar, Harro
    Blake, Derek
    Young, Kate
    Halliwell, Nicola
    Callister, Janis Bennion
    Toulson, Greg
    Richardson, Anna
    Gerhard, Alex
    Snowden, Julie
    Mann, David
    Neary, David
    Nalls, Michael A.
    Peuralinna, Terhi
    Jansson, Lilja
    Isoviita, Veli-Matti
    Kaivorinne, Anna-Lotta
    Holtta-Vuori, Maarit
    Ikonen, Elina
    Sulkava, Raimo
    [J]. NEURON, 2011, 72 (02) : 257 - 268
  • [22] MUTATIONS IN CU/ZN SUPEROXIDE-DISMUTASE GENE ARE ASSOCIATED WITH FAMILIAL AMYOTROPHIC-LATERAL-SCLEROSIS
    ROSEN, DR
    SIDDIQUE, T
    PATTERSON, D
    FIGLEWICZ, DA
    SAPP, P
    HENTATI, A
    DONALDSON, D
    GOTO, J
    OREGAN, JP
    DENG, HX
    RAHMANI, Z
    KRIZUS, A
    MCKENNAYASEK, D
    CAYABYAB, A
    GASTON, SM
    BERGER, R
    TANZI, RE
    HALPERIN, JJ
    HERZFELDT, B
    VANDENBERGH, R
    HUNG, WY
    BIRD, T
    DENG, G
    MULDER, DW
    SMYTH, C
    LAING, NG
    SORIANO, E
    PERICAKVANCE, MA
    HAINES, J
    ROULEAU, GA
    GUSELLA, JS
    HORVITZ, HR
    BROWN, RH
    [J]. NATURE, 1993, 362 (6415) : 59 - 62
  • [23] Pulmonary predictors of survival in amyotrophic lateral sclerosis: Use in clinical trial design
    Schmidt, EP
    Drachman, DB
    Wiener, CM
    Clawson, L
    Kimball, R
    Lechtzin, N
    [J]. MUSCLE & NERVE, 2006, 33 (01) : 127 - 132
  • [24] Spreading of amyotrophic lateral sclerosis lesions-multifocal hits and local propagation?
    Sekiguchi, Teruhiko
    Kanouchi, Tadashi
    Shibuya, Kazumoto
    Noto, Yu-ichi
    Yagi, Yohsuke
    Inaba, Akira
    Abe, Keisuke
    Misawa, Sonoko
    Orimo, Satoshi
    Kobayashi, Takayoshi
    Kamata, Tomoyuki
    Nakagawa, Masanori
    Kuwabara, Satoshi
    Mizusawa, Hidehiro
    Yokota, Takanori
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2014, 85 (01) : 85 - 91
  • [25] Review: Prion-like mechanisms of transactive response DNA binding protein of 43kDa (TDP-43) in amyotrophic lateral sclerosis (ALS)
    Smethurst, P.
    Sidle, K. C. L.
    Hardy, J.
    [J]. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2015, 41 (05) : 578 - 597